Evidence map›Paper›PMID 32395484›Full record

ArticleAnnals of translational medicine2020

Quantum biology in low level light therapy: death of a dogma.

Andrei P Sommer, Peter Schemmer, Attila E Pavláth, Horst-Dieter Försterling, Ádám R Mester, Mario A Trelles

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04628390 (Low Level 810nm Laser Therapy on Controlling Pain During a First Stage of Orthondontic Treatment), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04628390 naunknown statusnot on this map

Low Level 810nm Laser Therapy on Controlling Pain During a First Stage of Orthondontic Treatment

TypeinterventionalSponsorFundación Universitaria CIEORan2020 to 2021Enrolled60ConditionsMalocclusionArmsLaser, Placebo
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Photobiomodulation therapy.JADA foundational science · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Andrei P SommerFaculty of Science, ISRA University, Amman, Jordan.
Peter SchemmerGeneral, Visceral and Transplant Surgery, Medical University of Graz, Graz, Austria.
Attila E PavláthPast President American Chemical Society, Western Regional Research Center, Albany, CA, USA.
Horst-Dieter FörsterlingDepartment of Chemistry, Philipps University Marburg, Marburg, Germany.
Ádám R MesterNational Laser Therapy Centre, Péterfy Sándor Teaching Hospital, Budapest, Hungary.
Mario A TrellesPlastic-Aesthetic Surgery, Vilafortuny Laser Centre, Jumeirah, Dubai, United Arab Emirates.
American Chemical Society · USIsra University · JOJumeira University · AEMedical University of Graz · ATPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is shown that despite exponential increase in the number of clinically exciting results in low level light therapy (LLLT), scientific progress in the field is retarded by a wrong fundamental model employed to explain the photon-cell interaction as well as by an inadequate terminology. This is reflected by a methodological stagnation in LLLT, persisting since 1985. The choice of the topics is, by necessity, somewhat arbitrary. Obviously, we are writing more about the fields we know more about. In some cases, there are obvious objective reasons for the choice. Progress in LLLT is currently realized by a trial and error process, as opposed to a systematic approach based on a valid photon-cell interaction model.

methodsThe strategy to overcome the current problem consists in a comprehensive analysis of the theoretical foundation of LLLT, and if necessary, by introducing new interaction models and checking their validity on the basis of the two pillars of scientific advance (I) agreement with experiment and (II) predictive capability. The list of references used in this work, does contain a representative part of what has been done in the photon-cell interaction theory in recent years, considered as ascertained by the scientific community.

resultsDespite the immense literature on the involvement of cytochrome c oxidase (COX) in LLLT, the assumption that COX is the main mitochondrial photoacceptor for R-NIR photons no longer can be counted as part of the theoretical framework proper, at least not after we have addressed the misleading points in the literature. Here, we report the discovery of a coupled system in mitochondria whose working principle corresponds to that of field-effect transistor (FET). The functional interplay of cytochrome c (emitter) and COX (drain) with a nanoscopic interfacial water layer (gate) between the two enzymes forms a biological FET in which the gate is controlled by R-NIR photons. By reducing the viscosity of the nanoscopic interfacial water layers within and around the mitochondrial rotary motor in oxidatively stressed cells R-NIR light promotes the synthesis of extra adenosine triphosphate (ATP).

conclusionsBased on the results of our own work and a review of the published literature, we present the effect of R-NIR photons on nanoscopic interfacial water layers in mitochondria and cells as a novel understanding of the biomedical effects R-NIR light. The novel paradigm is in radical contrast to the theory that COX is the main absorber for R-NIR photons and responsible for the increase in ATP synthesis, a dogma propagated for more than 20 years.

Indexed as

adenosine triphosphate (ATP)biological field-effect transistor (FET)biostimulationcytochrome c oxidase (COX)interfacial waterLow level light therapy (LLLT)mitochondriaquantum biology

Identifiers

PMID32395484
PMCPMC7210155
OpenAlexW3015148351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.